Rationale and prognosis of repurposed drugs with risk stratification of patients in oxygen support in COVID-19: A systematic review and meta-analysis

Esther Jebarani Elangovan, Vanitha Shyamili Kumar, Adhithyan Kathiravan, Raghav Mallampalli, Tiju Thomas, Gnanasambandam Subramaniyam
doi: https://doi.org/10.1101/2020.10.04.20206516

Article Information

doi 
https://doi.org/10.1101/2020.10.04.20206516
History 
  • October 6, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Esther Jebarani Elangovan*,1,
  2. Vanitha Shyamili Kumar*,2,
  3. Adhithyan Kathiravan2,
  4. Raghav Mallampalli2,
  5. Tiju Thomas*,2 and
  6. Gnanasambandam Subramaniyam3
  1. 1Department of Biotechnology, Anna University, Chennai, India
  2. 2Indian Institute of Technology – Madras, Chennai, India
  3. 3Department of Pediatric Cardiology, Madras Medical College, Chennai, India
  1. ↵*Corresponding Author Dr.Tiju Thomas, Associate Professor, Indian Institute Of Technology, Madras, Chennai, India – 600036, Email: tijuthomas{at}iitm.ac.in, tt332{at}cornell.edu

  1. * these authors contributed equally and share first authorship

Back to top
Posted October 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Rationale and prognosis of repurposed drugs with risk stratification of patients in oxygen support in COVID-19: A systematic review and meta-analysis
Esther Jebarani Elangovan, Vanitha Shyamili Kumar, Adhithyan Kathiravan, Raghav Mallampalli, Tiju Thomas, Gnanasambandam Subramaniyam
medRxiv 2020.10.04.20206516; doi: https://doi.org/10.1101/2020.10.04.20206516
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area